Keytruda Gets a New Job

The US Food and Drug Administration (FDA) has granted accelerated approval to pembrolizumab (brand name Keytruda) for patients with classical Hodgkin lymphoma (cHL). Source: RX Wiki Please click on image for full article!

read more
Powered